The New Landscape of ABSSTI Treatment Opportunities to Improve Patient Care

ABSSTI Burden of Disease

ABSSTI Implications

Defining ABSSTI

Defining ABSSTI (cont)

Management of ABSSTI

Therapeutic Landscape Antimicrobial Therapy for Staphylococcal and Streptococcal ABSSTI

Adding to the Armamentarium Against ABSSTI Novel Agents

Relative Advantages and Disadvantages of Novel Agents for Treatment of ABSSTI

The Patient Who Presents to the ED With ABSSTI Admit to Hospital?

The Patient Who Presents to the ED With ABSSTI Discharge Home?

Should Cultures Be Done for All Patients With ABSSTI?

Is Double-empiric Therapy Indicated for Uncomplicated ABSSTI?

Is Double-empiric Therapy Indicated for Complicated ABSSTI? (cont)

Guidelines Lag Behind Advances Novel Long-acting Antibiotics

De-escalation and Duration of Antibiotic Therapy Important Stewardship Principles

Guidelines Are Guidelines

Do Patients Managed With I&D Need Antibiotics?

ED Primary Point of Entry for Patients With ABSSTI Due to MRSA

Care Transitions in the Emergency Department Streamlining Across the Continuum of Care and Standardizing the Management of ABSSTI

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)